Scientific Sessions 2024  /  Obesity and Cardiovascular Outcomes: A Lancet Journal Session  /  The evolving therapeutic landscape in obesity and the effect on cardiovascular outcomes
Logo

American Heart Association

  119
  0

Final ID:

The evolving therapeutic landscape in obesity and the effect on cardiovascular outcomes

  • Kosiborod, Mikhail  ( ST LUKES HEALTH SYSTEM , Kansas City , Missouri , United States )
    • Author Disclosures:
    Mikhail Kosiborod: DO have relevant financial relationships ; Consultant:35Pharma, Imbria Pharmaceuticals:Active (exists now) ; Consultant:Esperion Therapeutics, Structure Therapeutics:Active (exists now) ; Consultant:Eli Lilly, scPharmaceuticals:Active (exists now) ; Consultant:Dexcom, Sanofi, Youngene Therapeutics:Active (exists now) ; Consultant:Cytokinetics, Regeneron:Active (exists now) ; Consultant:Boehringer Ingelheim:Active (exists now) ; Research Funding (PI or named investigator):Boehringer Ingelheim:Active (exists now) ; Consultant:Bayer, Pharmacosmos:Active (exists now) ; Other (please indicate in the box next to the company name):AstraZeneca, Vifor Pharma - data analytic center fees:Active (exists now) ; Consultant:AstraZeneca, Pfizer, Vifor Pharma:Active (exists now) ; Research Funding (PI or named investigator):AstraZeneca, Pfizer:Active (exists now) ; Consultant:Arrowhead Pharmaceuticals:Active (exists now) ; Consultant:Applied Therapeutics:Active (exists now) ; Consultant:Amgen, NovoNordisk:Active (exists now) ; Consultant:Alnylam, Merck (Diabetes and Cardiovascular):Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Obesity and Cardiovascular Outcomes: A Lancet Journal Session

Saturday, 11/16/2024 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
Understanding the global burden of obesity and the implications for cardiovascular health

Ezzati Majid, Margozzini Paula, Phelps Nowell

Inequity and determinants of cardiovascular health in obesogenic environments

Lingvay Ildiko, Gulati Martha, Franks Paul

More abstracts from these authors:
Obesity Pharmacotherapy – where are we now?

Stanford Fatima, Kosiborod Mikhail

Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients with Heart Failure with Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial

Kosiborod Mikhail

You have to be authorized to contact abstract author. Please, Login
Not Available